Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model.

about

Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model.

Item

http://www.wikidata.org/entity/Q47180421

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Aromatase inhibitor use during ...... ncer in xenograft mouse model.

@en

Aromatase inhibitor use during ...... ncer in xenograft mouse model.

@nl

type

Item

label

Aromatase inhibitor use during ...... ncer in xenograft mouse model.

@en

Aromatase inhibitor use during ...... ncer in xenograft mouse model.

@nl

prefLabel

Aromatase inhibitor use during ...... ncer in xenograft mouse model.

@en

Aromatase inhibitor use during ...... ncer in xenograft mouse model.

@nl

P1476

Aromatase inhibitor use during ...... ancer in xenograft mouse model

@en

P2093

Atsushi Uekawa

http://www.w3.org/2001/XMLSchema#string

Junya Ito

http://www.w3.org/2001/XMLSchema#string

Mariko Nakajima

http://www.w3.org/2001/XMLSchema#string

Megumi Kashiwagi

http://www.w3.org/2001/XMLSchema#string

Nao Suzuki

http://www.w3.org/2001/XMLSchema#string

Naoki Okamoto

http://www.w3.org/2001/XMLSchema#string

Naomi Kashiwazaki

http://www.w3.org/2001/XMLSchema#string

Seido Takae

http://www.w3.org/2001/XMLSchema#string

Tai Kawahara

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate

Successful treatment of low-grade endometrial cancer in premenopausal women with an aromatase inhibitor after failure with oral or intrauterine progesterone.

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Risk of cancer after use of fertility drugs with in-vitro fertilisation.

Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer

The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.

Type I and II endometrial cancers: have they different risk factors?

Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?

P304

303-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEX368

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yodo Sugishita

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29300901

http://www.w3.org/2001/XMLSchema#string

P921

xenograft